Treace Medical Concepts (TMCI) FCF Margin (2020 - 2026)

Treace Medical Concepts has reported FCF Margin for 7 years, with the latest figure at 8.85% in Q1 2026.

• For the quarter ending Q1 2026, FCF Margin rose 761.0% year-over-year to 8.85%; the trailing twelve-month figure through Mar 2026 stood at 12.52% (up 501.0% YoY), and the FY2025 full-year result was 13.86%, up 943.0% from the prior year.
• FCF Margin for Q1 2026 stood at 8.85%, up from 16.67% in the prior quarter.
• The five-year high for FCF Margin was 8.85% in Q1 2026, with the low at 52.48% in Q2 2022.
• Historically, FCF Margin has averaged 23.2% across 5 years, with a median of 23.7% in 2025.
• Annual changes were most pronounced in 2022 — FCF Margin sank 3117 bps — and 2025, when it jumped 2306 bps.
• Treace Medical Concepts' FCF Margin stood at 15.45% in 2022, then surged by 82 bps to 2.76% in 2023, then plunged by 284 bps to 10.6% in 2024, then sank by 57 bps to 16.67% in 2025, then jumped by 153 bps to 8.85% in 2026.
• The last three FCF Margin figures came in at 8.85% (Q1 2026), 16.67% (Q4 2025), and 23.7% (Q3 2025), per Business Quant data.